Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs
- 1 June 2011
- journal article
- Published by Elsevier BV in Free Radical Biology & Medicine
- Vol. 50 (11), 1599-1609
- https://doi.org/10.1016/j.freeradbiomed.2011.03.008
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- The Nrf2-Keap1-ARE Signaling Pathway: The Regulation and Dual Function of Nrf2 in CancerAntioxidants and Redox Signaling, 2010
- Discovery of the Negative Regulator of Nrf2, Keap1: A Historical OverviewAntioxidants and Redox Signaling, 2010
- Loss of Kelch-Like ECH-Associated Protein 1 Function in Prostate Cancer Cells Causes Chemoresistance and Radioresistance and Promotes Tumor GrowthMolecular Cancer Therapeutics, 2010
- Multidrug-resistant protein-3 gene regulation by the transcription factor Nrf2 in human bronchial epithelial and non-small-cell lung carcinomaFree Radical Biology & Medicine, 2009
- RNAi-Mediated Silencing of Nuclear Factor Erythroid-2–Related Factor 2 Gene Expression in Non–Small Cell Lung Cancer Inhibits Tumor Growth and Increases Efficacy of ChemotherapyCancer Research, 2008
- Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancyProceedings of the National Academy of Sciences of the United States of America, 2008
- Identification of retinoic acid as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor alphaProceedings of the National Academy of Sciences of the United States of America, 2007
- Plant polyphenols: How to translate their in vitro antioxidant actions to in vivo conditionsIUBMB Life, 2007
- Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung CancerPLoS Medicine, 2006
- Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family membersBiochemical Journal, 1999